Shenzhen Kangtai Biological Products Co., Ltd. (SHE: 300601)

China flag China · Delayed Price · Currency is CNY
13.48
-0.13 (-0.96%)
Sep 9, 2024, 1:51 PM CST
-50.09%
Market Cap 15.15B
Revenue (ttm) 2.95B
Net Income (ttm) 516.21M
Shares Out 1.12B
EPS (ttm) 0.46
PE Ratio 29.29
Forward PE 15.57
Dividend 0.40 (2.94%)
Ex-Dividend Date Jun 14, 2024
Volume 5,718,160
Open 14.14
Previous Close 13.61
Day's Range 13.46 - 14.14
52-Week Range 13.46 - 34.18
Beta 0.82
Analysts n/a
Price Target n/a
Earnings Date Oct 25, 2024

About Shenzhen Kangtai Biological Products

Shenzhen Kangtai Biological Products Co., Ltd. researches, develops, produces, and sells various types of human vaccines in China. The company’s products include cell-free whitebait b-type haemophilus influenzae combined vaccine, SARS-COV-2 vaccine, recombinant hepatitis B vaccine, 23-valent pneumococcal polysaccharide vaccine, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccine, haemophilus influenzae type b conjugate vaccine, measles and rubella combined vaccine, 13-valent pneumococcal conjugate vaccine, ... [Read more]

Sector Healthcare
Founded 1992
Employees 1,902
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300601
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.